AZN
AstraZeneca PLC
NASDAQ: AZN · HEALTHCARE · DRUG MANUFACTURERS - GENERAL
$187.37
+1.17% today
Updated 2026-04-30
Market cap
$287.11B
P/E ratio
27.85
P/S ratio
4.89x
EPS (TTM)
$6.65
Dividend yield
—
52W range
$130 – $211
Volume
2.0M
AstraZeneca PLC (AZN) Financial statements
SEC filings — annual and quarterly data.
Profit margin
17.40%
Operating margin
21.60%
ROE
22.80%
ROA
8.19%
Debt/equity
0.61x
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2006 | $26.48B | $6.04B | 79.00% | 31.03% | 22.83% |
| 2007 | $29.56B | $5.59B | 78.28% | 27.38% | 18.93% |
| 2008 | $31.60B | $6.10B | 79.12% | 28.94% | 19.31% |
| 2009 | $32.80B | $7.52B | 82.40% | 35.19% | 22.93% |
| 2010 | $33.27B | $8.05B | 80.80% | 34.55% | 24.21% |
| 2011 | $33.59B | $9.92B | 82.06% | 38.09% | 29.52% |
| 2012 | $27.97B | $6.24B | 80.72% | 29.13% | 22.31% |
| 2013 | $25.81B | $2.56B | 79.61% | 14.38% | 9.90% |
| 2014 | $26.55B | $1.23B | 77.99% | 8.05% | 4.64% |
| 2015 | $24.71B | $2.83B | 81.20% | 16.65% | 11.43% |
| 2016 | $23.00B | $3.50B | 82.06% | 21.31% | 15.21% |
| 2017 | $22.46B | $3.00B | 80.78% | 16.37% | 13.36% |
| 2018 | $22.09B | $2.15B | 77.66% | 15.33% | 9.76% |
| 2019 | $24.38B | $1.33B | 79.82% | 11.99% | 5.47% |
| 2020 | $26.62B | $3.20B | 80.09% | 19.39% | 12.01% |
| 2021 | $37.42B | $112.00M | 66.76% | 2.82% | 0.30% |
| 2022 | $44.35B | $3.29B | 72.06% | 8.47% | 7.41% |
| 2023 | $45.81B | $5.96B | 81.95% | 17.88% | 13.00% |
| 2024 | $54.07B | $7.04B | 81.12% | 18.50% | 13.01% |
| 2025 | $58.74B | $10.26B | 81.90% | 23.40% | 17.46% |